Works in Cancer Biology & Therapy, 2015, Vol 16, Issue 4


Results: 15
    1

    Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway.

    Published in:
    Cancer Biology & Therapy, 2015, v. 16, n. 4, p. 623, doi. 10.1080/15384047.2015.1019185
    By:
    • Mu, Qingchun;
    • Wang, Lijun;
    • Yu, Fengbo;
    • Gao, Haijun;
    • Lei, Ting;
    • Li, Peiwen;
    • Liu, Pengfei;
    • Zheng, Xu;
    • Hu, Xitong;
    • Chen, Yong;
    • Jiang, Zhenfeng;
    • Sayari, Arash J;
    • Shen, Jia;
    • Huang, Haiyan
    Publication type:
    Article
    2
    3

    Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking.

    Published in:
    Cancer Biology & Therapy, 2015, v. 16, n. 4, p. 589, doi. 10.1080/15384047.2015.1019184
    By:
    • Bao, Xingfeng;
    • Zheng, Wanjun;
    • Sugi, Naoko Hata;
    • Agarwala, Kishan L;
    • Xu, Qunli;
    • Wang, Zichun;
    • Tendyke, Karen;
    • Lee, Winnie;
    • Parent, Lana;
    • Li, Wei;
    • Cheng, Hongsheng;
    • Shen, Yongchun;
    • Taylor, Noel;
    • Dezso, Zoltan;
    • Du, Hong;
    • Kotake, Yoshihiko;
    • Zhao, Nanding;
    • Wang, John;
    • Postema, Maarten;
    • Woodall-Jappe, Mary
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15